5 December 2025 - The agenda for the December 2025 PBAC meeting is now available.

The Committee will consider submissions for the following health care technologies:

• Blinatumomab (Blincyto) - restriction change
• Eplerenone (Insptra) - restriction change
• Raxtozinameran (Comirnaty Omicron XBB.1.5) - new vaccine
• Pembrolizumab (Keytruda) - restriction change
• Respiratory syncytial virus vaccine (adjuvanted) (Arexvy) - new indication
• Seladelpar lysine dihydrate (Livdelzi) - new medicine
• Velmanase alfa (Lamzede) - new indication

Read PBAC agenda